In veterinary medicine, canine serum TK1 activity has also been shown to be a useful diagnostic and prognostic biomarker for hematological malignancies and it can be used to monitor cancer treatment [8–10, 25, 30]. This evidence concerns the gene TK1 and hematologic disorder.